Bone metastases from renal cell carcinoma: 4 years after aggressive surgeries and anti-angiogenic therapy.
Mouadh NefissHichem AbidMohamed Amine GharbiRamzi BouzidiAnis TeborbiPublished in: Clinical case reports (2022)
Management of bone metastases from renal cell carcinoma (RCC) has significantly changed after the era of targeted therapy that improved the overall survival (OS). Surgical decision-making remains a subject of controversy. We report a case of pelvic bone metastasis from RCC, 2 months after nephrectomy and surgery of a revealing clavicular metastasis.
Keyphrases
- renal cell carcinoma
- decision making
- minimally invasive
- coronary artery bypass
- robot assisted
- bone mineral density
- rectal cancer
- stem cells
- surgical site infection
- free survival
- mesenchymal stem cells
- acute coronary syndrome
- coronary artery disease
- editorial comment
- bone regeneration
- bone loss
- cell therapy
- percutaneous coronary intervention
- replacement therapy
- smoking cessation